OCM™ Wound Matrix from Omeza
Comprehensive Therapy Across Every Phase of Wound Healing
A drug–device wound matrix designed to support healing from inflammation through remodeling
OCM™ wound matrix is a first-of-its-kind drug–device combination product developed to provide comprehensive support across all stages of wound healing. Delivered in a single-use, disposable vial, OCM™ offers a practical solution for managing complex and chronic wounds that have stalled or failed to progress.
OCM™ combines time-released pharmaceutical-grade elements within an amorphous wound matrix that conforms to the wound bed, helping create an optimal healing environment while reducing treatment burden for both clinicians and patients.
Product Overview
OCM™ is designed to migrate into tunnels, crevices, and irregular wound geometries, delivering sustained support directly where it is needed.
The wound matrix works by:
Reducing inflammation
Supporting cellular proliferation
Assisting tissue remodeling
Helping reduce the impact of biofilm
By covering the entire wound surface, OCM™ acts as both a physical barrier and a biologically active scaffold, supporting healing processes throughout the wound lifecycle.
WHY CHOOSE OMC™
Drug–device combination therapy
Supports all phases of wound healing
Time-released pharmaceutical-grade components
Conforms to complex wound geometries
Helps reduce inflammation and biofilm impact
Supports granulation, epithelialization, and remodeling
Absorbable and biodegradable over time
Single-use, disposable format
Simple application with minimal ongoing mainte
Join Us in Advancing Wound Care
At Bobber Biotech, we partner with innovators to deliver advanced wound care technologies that simplify treatment while improving outcomes. OCM™ expands our portfolio with a comprehensive, biologically active wound matrix designed for today’s most challenging wounds.
